Selvita S.A. Logo

Selvita S.A.

ISIN: PLSLVCR00029 | Ticker: SLV | LEI: 25940057WQ9YP5MOQF28

About Selvita S.A.

Company Description

We are one of the largest preclinical contract research organizations in Europe, driven by a clear mission:

to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development.

We have grown from a 20-people start-up to a global organization, yet we still focus on the same goal:
to become a true partner for our Clients, providing multidisciplinary support in their toughest research challenges.

We provide high-quality drug discovery and drug development services. We have the necessary expertise and know-how to support drug discovery projects across a broad range of therapeutic areas. We offer a range of stand-alone or fully integrated drug discovery and development solutions spanning the entire value chain from early drug discovery to preclinical development.

Year founded


Served area



Bobrzyńskiego 14, 30-348 Kraków – Poland

Filings & Publications


Report Q1 H1 Q3 FY
Consolidated Report pl
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Shareholder information

Shares outstanding



Oct. 1, 2019

Stock exchange(s)

Warsaw Stock Exchange



Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.